Literature DB >> 14666383

Challenging cases in thyroid cancer: a multidisciplinary approach.

Michael Tuttle1, Richard Robbins, Steven M Larson, H William Strauss.   

Abstract

Recurrent thyroid cancer can present many complex management problems. Unfortunately, recurrent thyroid cancer is often refractory to radioiodine therapy. The proper use of external beam irradiation and surgical interventions can provide regional control of localized recurrences. Because of the complex nature of these patients, a multidisciplinary team approach to management which includes specialists in thyroid medicine and surgery, head and neck radiotherapy, and nuclear medicine often is required to provide individualized, optimal multimodality treatment recommendations. In this article we review a multidisciplinary team approach to a patient with widespread, radioiodine-refractory bone metastases from follicular thyroid cancer and to a patient with unresectable central neck recurrence of papillary thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14666383     DOI: 10.1007/s00259-003-1324-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  34 in total

Review 1.  The management of metastatic differentiated thyroid carcinoma.

Authors:  S I Sherman
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

2.  Thyroid cancer dosimetry using clearance fitting.

Authors:  E E Furhang; S M Larson; P Buranapong; J L Humm
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

Review 3.  Evaluation and management of the solid thyroid nodule.

Authors:  H B Burch
Journal:  Endocrinol Metab Clin North Am       Date:  1995-12       Impact factor: 4.741

4.  Diagnosis of "follicular neoplasm": a gray zone in thyroid fine-needle aspiration cytology.

Authors:  Zubair W Baloch; Seth Fleisher; Virginia A LiVolsi; Prabodh K Gupta
Journal:  Diagn Cytopathol       Date:  2002-01       Impact factor: 1.582

5.  Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

Authors:  W Wang; S M Larson; M Fazzari; S K Tickoo; K Kolbert; G Sgouros; H Yeung; H Macapinlac; J Rosai; R J Robbins
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration.

Authors:  R M Tuttle; H Lemar; H B Burch
Journal:  Thyroid       Date:  1998-05       Impact factor: 6.568

7.  Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.

Authors:  M Schlumberger; M Tubiana; F De Vathaire; C Hill; P Gardet; J P Travagli; P Fragu; J Lumbroso; B Caillou; C Parmentier
Journal:  J Clin Endocrinol Metab       Date:  1986-10       Impact factor: 5.958

8.  Pure follicular thyroid carcinoma: impact of therapy in 214 patients.

Authors:  R L Young; E L Mazzaferri; A J Rahe; S G Dorfman
Journal:  J Nucl Med       Date:  1980-08       Impact factor: 10.057

Review 9.  Positron emission tomography in thyroid cancer management.

Authors:  Steven M Larson; Richard Robbins
Journal:  Semin Roentgenol       Date:  2002-04       Impact factor: 0.800

Review 10.  Follow-up of differentiated thyroid cancer.

Authors:  Furio Pacini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-06-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.